semaxinib and Spinal-Cord-Neoplasms

semaxinib has been researched along with Spinal-Cord-Neoplasms* in 1 studies

1 trial(s) available for semaxinib and Spinal-Cord-Neoplasms

Article	Year
Antiangiogenic therapy for von Hippel-Lindau disease. JAMA, 2004, Feb-25, Volume: 291, Issue:8 Topics: Adult; Angiogenesis Inhibitors; Brain Neoplasms; Female; Hemangioblastoma; Humans; Indoles; Male; Middle Aged; Pyrroles; Retinal Neoplasms; Spinal Cord Neoplasms; Treatment Outcome; Vascular Endothelial Growth Factor A; von Hippel-Lindau Disease	2004